The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
Victoza may not be safe to receive during pregnancy and breastfeeding. Keep reading for specific information about reproductive health and Victoza. For a comprehensive look, see this other article ...
The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza ...
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
healthday on MSN2d
FDA Approves Generic GLP-1 Medicine For Diabetes TreatmentThe U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
Novo Nordisk's Victoza (liraglutide) has become the only approved diabetes drug in the GLP-1 agonist class shown to demonstrate a cardiac safety benefit, although it faces competition from a ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback